The EGFR pathway is inhibited by anti-EGFR antibodies, which leads to an inhibition of magnesium reabsorption by transient receptor potential cation channel, subfamily M, member 6 (TRPM6) in the renal tubules, accompanying hypomagnesemia [8, 19]. Here, TRPM6 is linked to familial primary hypomagnesemia.